GENinCode (LON:GENI) Shares Up 24.3% – What’s Next?

GENinCode Plc (LON:GENIGet Free Report) shot up 24.3% during mid-day trading on Tuesday . The company traded as high as GBX 4.98 ($0.06) and last traded at GBX 4.97 ($0.06). 420,112 shares were traded during trading, a decline of 59% from the average session volume of 1,017,303 shares. The stock had previously closed at GBX 4 ($0.05).

GENinCode Trading Up 2.6 %

The stock has a market capitalization of £7.08 million, a P/E ratio of -80.00 and a beta of 0.66. The business has a 50 day simple moving average of GBX 3.84 and a 200-day simple moving average of GBX 4.95. The company has a debt-to-equity ratio of 9.27, a quick ratio of 15.89 and a current ratio of 2.60.

About GENinCode

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Featured Articles

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.